[FEATURES OF THE USE OF ANTIBACTERIAL DRUGS IN PATIENTS WITH COVID-19].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
; 30(s1): 1044-1049, 2022 Dec 15.
Article
in Russian
| MEDLINE | ID: covidwho-2117152
ABSTRACT
The review traces the evolution of the section on the use of antibacterial drugs in the temporary guidelines of the Ministry of Health for the treatment of a new coronavirus infection. Diagnostic approaches that play an important role in deciding on the need and duration of antibacterial therapy are presented. Routine use of fluoroquinolones should be restricted due to the adverse safety spectrum. According to existing data, the tactic of short courses of antibacterial therapy for community-acquired pneumonia are not inferior in effectiveness to longer courses. Unjustified prescribing of antibiotics increases the cost of medical care, promotes the selection of resistant pathogens and leads to adverse side effects. Timely updating of clinical recommendations, implementation of programs to control the appointment of antibacterial agents in medical organizations and strengthening the role of the clinical pharmacology service can reduce these adverse events.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia
/
Community-Acquired Infections
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Humans
Language:
Russian
Journal:
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
Journal subject:
Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS